#160933

RLUN001-2 Lung cancer organoid

Cat. #160933

RLUN001-2 Lung cancer organoid

Cat. #: 160933

Sub-type: Organoids

Unit size: 40-100 uL of cell pellet/vial, 1ml

Organism: Human

Tissue: Lung

£2,500.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Medical-Industrial Translational Research Center

Institute: Fukushima Medical University

Primary Citation: Takahashi et al. 2019. Cells 20: 481. PMC6562414

Tool Details
Handling
Application Details
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY

  • Tool name: RLUN001-2 Lung cancer organoid
  • Alternate name: RLUN001-2, RLUN1-2, RLUN1, RLUN001
  • Cancer: Lung cancer
  • Cancers detailed: Lung;Papillary adenocarcinoma
  • Research fields: Cancer
  • Tool sub type: Organoids
  • Organism: Human
  • Tissue: Lung
  • Gender: Female
  • Growth properties: Suspension
  • Application: 3D cell culture
  • Description: A series of novel patient-derived organoids (PDOs) have been constructed from different tumor tissue types under the Fukushima Translational Research Project, designated as F-PDO. F-PDOs form large cell clusters with a morphology similar to the original tumor and can be cultured for more than six months. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of F-PDOs were similar to their source tumors, even after long-term growth in culture conditions
  • Biosafety level: 1

Handling

  • Format: Frozen
  • Passage number: 5
  • Growth medium: Cancer Cell Expansion Media plus (Fujifilm Wako Pure Chemical, Ltd.).
  • Temperature: 37° C
  • Atmosphere: 5% CO2
  • Volume: 1 ml
  • Storage medium: CELLBANKER 2
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Pathogen and stelility test; Comprehensive gene expression analysis; Cancer panel sequencing; Whole exome sequencing
  • Mycoplasma free: Yes
  • Biosafety level: 1

Application Details

  • Application: 3D cell culture

References

  • Takahashi et al. 2019. Cells 20: 481. PMC6562414

Documentation